Clinical Trial
Published on 25 Mar 2025
Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial
in Hepatobiliary Diseases
- 340 views
Clinical Trial
Published on 25 Mar 2025
in Hepatobiliary Diseases
Original Research
Accepted on 24 Mar 2025
in Hepatobiliary Diseases
Original Research
Accepted on 24 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 24 Mar 2025
in Hepatobiliary Diseases
Case Report
Published on 24 Mar 2025
in Hepatobiliary Diseases
Case Report
Published on 19 Mar 2025
in Hepatobiliary Diseases
Review
Published on 17 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 14 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 13 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 12 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 12 Mar 2025
in Hepatobiliary Diseases
Original Research
Accepted on 11 Mar 2025
in Hepatobiliary Diseases
Original Research
Published on 10 Mar 2025
in Hepatobiliary Diseases
Review
Published on 10 Mar 2025
in Hepatobiliary Diseases
Review
Published on 07 Mar 2025
in Hepatobiliary Diseases
Case Report
Published on 05 Mar 2025
in Hepatobiliary Diseases